LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW. 1 ONE TYPE IS PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID (MY’-uh-loyd) LEUKEMIA.

SOME PATIENTS WITH C-M-L MAY HAVE DIFFICULTY FINDING A TREATMENT THAT’S RIGHT FOR THEM.

ALMOST 15% OF C-M-L PATIENTS DISCONTINUE THEIR TREATMENT IN THE FIRST YEAR DUE TO SIDE EFFECTS, SO HAVING DIFFERENT OPTIONS IS CRITICAL.3-7

HERE TO SHARE HER OWN EXPERIENCE BEING DIAGNOSED WITH PHILADELPHIA CHROMOSOME-POSITIVE C-M-L IN CHRONIC PHASE AND HOW SHE FOUND A TREATMENT THAT WORKED FOR HER, IS TEACHER AND C-M-L PATIENT, JEN. AND HERE TO TALK ABOUT TREATING ADULTS WITH C-M-L, IS DR. JAMES DUGAN (DOO’-guhn.)

HCP Bio: Dr. James Dugan

Dr. James Dugan is a hematology/oncology specialist, and the physician lead for the transplant and cellular therapy department for Novant Health Cancer Institute in Winston-Salem, North Carolina.

Dr. Dugan was drawn to the field of oncology by the opportunity to improve a person’s life during a difficult time. He believes that to properly treat the whole person and not just the disease, physicians need to engage in active conversations with the patient throughout the treatment process. Dr. Dugan approaches medicine and oncology as a partnership between the physician and the patient.

Dr. Dugan is a member of the American Society of Hematology, as well as the American Society for Transplant and Cellular therapy. His membership in these organizations keeps him up-to-date on the latest research and treatment options in the field.

When he is not seeing patients, Dr. Dugan enjoys time with his wife and three daughters. He is an outdoor enthusiast who enjoys skiing, scuba diving, kite surfing, and long-distance running. He is passionate about the shared human experience and loves meeting new people and exploring new ideas and places.

Patient Bio: Jen

In 2014, Jen was diagnosed with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).
Prior to her diagnosis, Jen devoted her career to serving others. After dedicating 20 years to running inner-city youth programs, Jen became a social worker, supporting women as they rebuilt their lives after incarceration or experiencing domestic violence.
Jen was actively working as a social worker when she was diagnosed with CML. Unfortunately, her diagnosis required her to step away from her career for a period of time. Working closely with her doctor, she navigated the treatment landscape to find a treatment option that worked for her.
Today, she is a teacher in her rural community, educating K-8 students in a one-room schoolhouse. She is also passionate about sharing her journey and advocating for other adults with CML, helping them access the information and support they need to have meaningful conversations with their doctors and navigate their own patient journeys.

LearnCML.com

The post LEUKEMIA IS A TYPE OF CANCER THAT AFFECTS THE BLOOD OR BONE MARROW. appeared first on Good News!.

Type 1 diabetes can’t be prevented or cured. However, it can be detected early through autoantibody screening before any noticeable symptoms arise, before insulin is required, and potentially before any serious complications occur. One such complication is diabetic ketoacidosis (DKA), a serious healthcare crisis that can be life-threatening. Early screening may help people potentially reduce their risk of going through DKA by up to 50%.

There’s a powerful social movement underway called “The 1 Pledge” that includes diverse voices of the type 1 diabetes community. The goal of the movement is to take action and get screened. Anyone can be screened for type 1 diabetes-related autoantibodies. By getting screened for type 1 diabetes early, people may give themselves and their families more time to prepare and plan for the future.

In an effort to spread the word about The 1 Pledge movement and the importance of screening for type 1 diabetes ahead of April 15 (Type 1 Diabetes Day), we invite you to join Dr. Michael B. Natter – a leading, New York-based Endocrinologist (who specializes in treating people with diabetes)

Dr. Natter has type 1 diabetes himself, having been diagnosed at age nine. Dr. Natter will discuss risk factors for type 1 diabetes and who should get screened. He will also talk about The 1 Pledge and the power of creating a plan of action to get screened, from his perspective as both a healthcare provider and a person living with type 1 diabetes.

Interview is courtesy: Sanofi

#diabetes #disease #screenfortype1 #thepledge #sanofi #type1 #insulin #diabetic #therapy #lifelongtherapy #ipledge #the1pledge #families #endocrinologist #diaagnosed #healthcare

The post TYPE 1 DIABETES IS ON THE RISE IN THIS COUNTRY. CURRENTLY, ABOUT 1.24 MILLION AMERICANS LIVE WITH THE DISEASE, AND THAT NUMBER IS EXPECTED TO GROW TO FIVE MILLION BY 2050… appeared first on Good News!.

During National Cancer Survivors Month, people around the country are recognizing the more than 16.9 million cancer survivors in the U.S. who are living with, through, and beyond their disease. www.lls.org

One of the most innovative treatments giving hope to people with blood cancers such as lymphoma, leukemia or myelomas is CAR T-cell therapy.1
• CAR T-cell therapies are made from a patient’s own blood cells and use the immune system to identify and attack cancer cells.2
• These innovative treatments have shown to be potentially life-saving therapies for patients with certain blood cancers, like large B-cell lymphoma (LBCL), which is the most common form of non-Hodgkin lymphoma and can be aggressive.2,3
• However, awareness of CAR T-cell therapy among potentially eligible patients in the U.S. is low – only about 1 out of 5 are aware of the therapy as a treatment option.4

Michael, a small business owner and father of three girls living in New Jersey, was diagnosed with LBCL in October 2018 and was treated with chemotherapy which he described as “pretty aggressive.” His cancer quickly returned – only four months later – and he decided to participate in a clinical trial for CAR T-cell therapy. Today he is 3+ years cancer-free.

Dr. Lori Leslie, a hematologist and oncologist at Hackensack Meridian John Theurer Cancer Center in New Jersey, treats people with blood cancers and has seen firsthand their devastating impact particularly for those whose cancer returns. Dr. Leslie, who treated Michael with CAR T-cell therapy, is available to discuss how recent treatment advances like CAR T-cell therapies offer people like Michael hope.

Michael and Dr. Leslie speak about CAR T-cell therapies for cancers like LBCL and how eligible patients and caregivers can learn more about these innovative treatments.

Interview is courtesy: Kite, a Gilead Company

1Siegel RL, Miller KD, Fuchs HE. Cancer statistics, 2022. CA Cancer J Clin. 2022;70:7-33.
2Zhao L, Cao YK. Engineered T cell therapy for cancer in the clinic. Front Immunol. 2019;10:1-20.
3National Cancer Institute. Cancer stat facts: Non-Hodgkin lymphoma. https://seer.cancer.gov/statfacts/html/nhl.html. Accessed May 10, 2022.
4 Data on File.

#michael #drlorileslie #car #t-cell #therapy #cancer #lbcl #patients #caregivers #innovativetreatments #kitegileadcompany #bloodcells #cancersurvivors #lls #b-cell

The post June is National Cancer Survivors Month appeared first on Good News!.

Non-small cell lung cancer (NSCLC) is the most common form, accounting for approximately 85% of all lung cancers.2 Many people diagnosed with early-stage NSCLC have surgery to remove the cancer; however, for approximately half of these patients, the cancer unfortunately returns.3 Experts agree there is an urgent need for enhanced screening uptake — which has hovered around five percent in recent years amongst those eligible to receive it4 — as well as improved treatment options in early-stage NSCLC to help prevent devastating cancer recurrences.

Studies have shown that treatments beyond chemotherapy, including targeted therapy and now immunotherapy – a type of personalized cancer treatment that activates the immune system to fight cancer – may help improve outcomes for certain patients with early-stage NSCLC after surgery.5 What’s promising is that these studies have now led to U.S. Food and Drug Administration approvals in the post-surgery setting to help reduce the risk of recurrence for patients with specific types of early-stage NSCLC, introducing a new era for these lung cancer patients.

Dr. David Carbone, Professor of Internal Medicine and Director of the James Thoracic Oncology Center at Ohio State University Medical Center will discuss the latest progress, including one of the most recent developments in early-stage lung cancer for patients.

Interview courtesy: Genentech

1 ACS. Key Statistics for Lung Cancer. 2022. Accessed from: https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html.
2 Molina et al. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clin Proc. 2008 May; 83(5): 584–594. Accessed September 27, 2021.
3 Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin
Oncol. 2014;5(5):1048-1054. doi:10.5306/wjco.v5.i5.1048
4 Fedewa SA, Kazerooni EA, Studts JL, et al. State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States. JNCI: The Journal of the National Cancer Institute. doi: 10.1093/jnci/djaa170
5 Zappa et al. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun; 5(3): 288–300. doi:
10.21037/tlcr.2016.06.07.

#davidcarbone #lungcancer #genentech #americancancersociety #factsfigures #disease #aminotherapy #etizolam #go2foundation #nsclc #surgery #chemotherapy #medicine #treatments #patients

The post EXCITING PROGRESS IN DIAGNOSING AND TREATING EARLY-STAGE LUNG CANCER appeared first on Good News!.

Midtown Physical Therapy

 
Listen to “Rachel Williams Physical Therapist Myofascial Release 113 West 78th Street, NY, NY” on Spreaker.

Upper West Side MPT

Upper West Side Midtown Physical Therapy is a small physical-therapist-owned practice, offering a comfortable atmosphere in a private outpatient setting.
Our compassionate physical therapists work with you one-on-one to treat you with today’s most advanced hands-on physical therapy techniques, customized to your personal needs.

Outcomes

We will work with you to define your physical therapy goals, and then provide every effort to help you achieve those goals.  Through restoring function and optimizing physical health, we will help improve your life for daily activities, exercise and athletic endeavors.

Try and feel better for life!

http://www.midtownpt.com

MAKE AN APPOINTMENT

SCHEDULE NOW

#physical #therapy #myofascial #release #health #goals #activities #athletic #exercise

The post Rachel Williams Physical Therapist Myofascial Release 113 West 78th Street, NY, NY appeared first on Good News!.

https://www.myofascialrelease.com
100,000 practitioners taught
this is the technique I’m using,
A. Once a week with Expert Rachel Williams (Can do Virtual intro session) with some home work
B. Once a week with another PT Therapist in her office session more traditional PT and Pilates Rack for fun!! homework

Here is a very informative physical therapy lecture from UCSF PT it was very interesting

“The Role of Fascia in Movement and Function” on YouTube
https://youtu.be/raCBeQ-gXfs

Myofacial Therapy addition info

https://youtu.be/v54l3wDTJHg

https://youtu.be/uzy8-wQzQMY

The post Welcome to Myofascial Release – John F. Barnes appeared first on Good News!.

The post Custom Performance, 295 Madison Ave., NY,NY. we speak to Founder, Wendy Winn, PT, OCS, 2014. appeared first on Good News!.

CKD is a progressive condition and patients with CKD have an increased risk of having heart disease.[1][3] However, most patients don’t know they have CKD, in large part because it is a “silent” disease, with most patients feeling no symptoms until the disease has progressed.[4] In fact, while approximately 15% of US adults are living with CKD, 9 in 10 are unaware they have CKD.[1]

Now, a new treatment option has been proven to help slow the progression of CKD – a huge scientific innovation for CKD patients at risk of progression with and without T2D. This approval is the most significant advancement in the treatment of CKD in over 20 years.

Because CKD may be overlooked until symptoms appear at advanced stages, it is especially important to be aware of risk factors and the serious complications that can occur.[1][5]

CKD tends to get worse over time, so the earlier treatment starts, the better the patient outcomes are. [3]

On May 19, Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, will be available to discuss the latest treatment option approved by the FDA. Dr. Skolnik will also discuss risk factors and the importance of early detection of CKD.

Interview Courtesy: AstraZeneca

1. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2019. https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html.

2. AstraZeneca. Diagnose CKD Now. https://www.diagnoseckdnow.com/

3. Centers for Disease Control and Prevention. Chronic Kidney Disease Basics. www.cdc.gov/kidneydisease/basics.html.

4. National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Disease Statistics for the United States. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease.

5. National Kidney Foundation. Estimated Glomerular Filtration Rate (Egfr). https://www.kidney.org/content/gfr]

#astrazeneca #farxiga #kidney #disease #health #chronic #patient #risk #diabetes #treatment #therapy #heart #ckd #neil #skolnik #thomas #jefferson #medicine #medical #family #factors

The post THE FIRST MAJOR DEVELOPMENT IN 20 YEARS TO HELP MANAGE CHRONIC KIDNEY DISEASE IN PATIENTS AT RISK OF PROGRESSION WITH AND WITHOUT TYPE 2 DIABETES appeared first on Good News!.

As the country increasingly begins to open back up following the pandemic closures, Paws of War will begin providing Pet Therapy once again with the mission of putting smiles back on the faces of their local community. This particular event will be held at one of the local nursing homes; The Smithtown Center for Rehabilitation and Nursing Care.
Our local communities and those in the nursing homes, including the Veterans residing there, always enjoy getting visits from therapy dogs. Paws of War will be providing therapy dog services to the Smithtown Center on Wednesday, June 23, 2021.

Paws of War rescues, trains and places rescues dogs and cats to serve and provide independence to our Veterans and First Responders who suffer the traumatic effects of wars and disasters. They do this so our heroes in need can experience the therapeutic relief and unconditional love only a companion animal or service dog can bring. Additionally, the organization also provides Pet Therapy services and helps soldiers relocate their rescued pets back to America after deployment through their War-Torn Pups and Cats Program.

The organization will have three to four teams that will be providing Pet Therapy Services to the residents that are currently residing at the Smithtown Center. Pet Therapy will provide moral support, help increase morale, provide overall comfort and social interaction to the residents.

WHEN:
Wednesday, June 23, 2021 at 11:00 am

WHERE:
Smithtown Center for Rehabilitation & Nursing Care
391 N. Country Rd. Smithtown, New York 11787

MEDIA CONTACT: Cher Murphy PR (571) 263-2128 or cher@chermurphypr.com

ABOUT:

Paws of War is a nonprofit 501(c)(3) charitable organization that provides assistance to military members and their pets, rescues and trains dogs to be service dogs, and provides therapy dogs to veterans. To learn more about Paws of War and the programs provided or to make a donation visit its site at: http://pawsofwar.org

The post Paws of War to Hold Pet Therapy Event at Smithtown Center for Rehabilitation & Nursing Care appeared first on Good News!.

Social isolation and loneliness are immense societal challenges that have a real impact on both our physical and mental health. Both are common issues and very serious ones. According to an AARP survey, one in three adults aged 45 and older are lonely[1]. And research shows loneliness is as deadly as smoking 15 cigarettes per day[2], making it as much a public health concern as obesity.

The loneliness epidemic has long been a major societal issue. COVID-19 has undoubtedly made it worse.[3]

Fortunately, research shows that interaction with pets may have a positive impact on both our mental and physical wellbeing from childhood well into old age.

May is National Mental Health Awareness Month and Mars Petcare is partnering with Virginia Commonwealth University (VCU) Health’s Center for Human-Animal Interaction and its Dogs on Call therapy dog team on a pilot study exploring the effectiveness of therapy dog interventions in improving both loneliness and related health outcomes for older adults in hospital settings.

Veterinarian Angela Hughes, PhD, DVM, and Nancy Gee, PhD, Director of the Center for Human Animal Interaction at Virginia Commonwealth University, discusses the issue of loneliness among older Americans and reveal the goals of the therapy dog study surrounding this issue. This new study – and the field of research into Human-Animal Interaction (HAI) – is all about exploring the potential of the incredible bond that pets and people can have and the role each can play in making life better for the other.

Interview is courtesy: Mars Petcare

http://marspetcare.com/
https://chai.vcu.edu/
https://www.waltham.com/

#loneliness #solutions #social #isolation #physical #mental #health #aarp #smoking #obesity #covid #worse #pets #mars #petcare #veterinarian #angela #hughes #awareness #therapy #dog #united #states

The post Shining a Spotlight on the Loneliness Epidemic in the U.S. appeared first on Good News!.